Skip to main content
Top
Published in: Forensic Science, Medicine and Pathology 3/2018

01-09-2018 | Original Article

The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study

Authors: Julia Ebert, Jan Peter Sperhake, Olaf Degen, Ann Sophie Schröder

Published in: Forensic Science, Medicine and Pathology | Issue 3/2018

Login to get access

Abstract

In Hamburg, Germany, the initiation of HIV post-exposure prophylaxis (HIV PEP) in cases of sexual violence is often carried out by forensic medical specialists (FMS) using the city’s unique Hamburg Model. FMS-provided three-day HIV PEP starter packs include a combination of raltegravir and emtricitabine/tenofovir. This study aimed to investigate the practice of offering HIV PEP, reasons for discontinuing treatment, patient compliance, and whether or not potential perpetrators were tested for HIV. We conducted a retrospective study of forensic clinical examinations carried out by the Hamburg Department of Legal Medicine following incidents of sexual violence from 2009 to 2016. One thousand two hundred eighteen incidents of sexual violence were reviewed. In 18% of these cases, HIV PEP was initially prescribed by the FMS. HIV PEP indication depended on the examination occurring within 24 h after the incident, no/unknown condom use, the occurrence of ejaculation, the presence of any injury, and the perpetrator being from population at high risk for HIV. Half of the HIV PEP recipients returned for a reevaluation of the HIV PEP indication by an infectious disease specialist, and just 16% completed the full month of treatment. Only 131 potential perpetrators were tested for HIV, with one found to be HIV positive. No HIV seroconversion was registered among the study sample. Provision of HIV PEP by an FMS after sexual assault ensures appropriate and prompt care for victims. However, patient compliance and completion rates are low. HIV testing of perpetrators must be carried out much more rigorously.
Literature
1.
go back to reference World Health Organization. Guidelines for medico-legal care for victims of sexual violence. Geneva: World Health Organization; 2003. World Health Organization. Guidelines for medico-legal care for victims of sexual violence. Geneva: World Health Organization; 2003.
2.
go back to reference Resnick H, Monnier J, Seals B, Holmes M, Nayak M, Walsh J, et al. Rape-related HIV risk concerns among recent rape victims. J Interpers Violence. 2002;17:746–59.CrossRef Resnick H, Monnier J, Seals B, Holmes M, Nayak M, Walsh J, et al. Rape-related HIV risk concerns among recent rape victims. J Interpers Violence. 2002;17:746–59.CrossRef
6.
go back to reference Schröder AS, Hertling S. Medizinische Versorgung von Opfern sexualisierter Gewalt. In: Grassberger M, Yen K, Türk EE, editors. Klinisch-forensische Medizin. Vienna: Springer Vienna; 2013. p. 357–66.CrossRef Schröder AS, Hertling S. Medizinische Versorgung von Opfern sexualisierter Gewalt. In: Grassberger M, Yen K, Türk EE, editors. Klinisch-forensische Medizin. Vienna: Springer Vienna; 2013. p. 357–66.CrossRef
7.
go back to reference Landovitz RJ, Currier JS. Clinical practice: postexposure prophylaxis for HIV infection. N Engl J Med. 2009;361:1768–75.CrossRefPubMed Landovitz RJ, Currier JS. Clinical practice: postexposure prophylaxis for HIV infection. N Engl J Med. 2009;361:1768–75.CrossRefPubMed
8.
go back to reference Tsai CC, Emau P, Follis KE, Beck TW, Benveniste RE, Bischofberger N, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol. 1998;72:4265–73.PubMedPubMedCentral Tsai CC, Emau P, Follis KE, Beck TW, Benveniste RE, Bischofberger N, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol. 1998;72:4265–73.PubMedPubMedCentral
9.
go back to reference Schmiedel S, Hertling S, Degen O, van Lunzen J, Polywka S, Seifert D, et al. Postexpositionsprophylaxe bei Gewaltopfern. Hamb Ärztebl. 2009;63:35–6. Schmiedel S, Hertling S, Degen O, van Lunzen J, Polywka S, Seifert D, et al. Postexpositionsprophylaxe bei Gewaltopfern. Hamb Ärztebl. 2009;63:35–6.
10.
go back to reference Seifert D, Anders S, Franke B, Schröder J, Gehl A, Heinemann A, et al. Modellprojekt zur Implementierung eines medizinischen Kompetenzzentrums für Gewaltopfer in Hamburg. Rechtsmedizin. 2004;14 Seifert D, Anders S, Franke B, Schröder J, Gehl A, Heinemann A, et al. Modellprojekt zur Implementierung eines medizinischen Kompetenzzentrums für Gewaltopfer in Hamburg. Rechtsmedizin. 2004;14
11.
go back to reference Müller ARE. HIV Postexpositionsprophylaxe in der Rechtsmedizin. Dissertation. Hamburg: Universität Hamburg; 2012. Müller ARE. HIV Postexpositionsprophylaxe in der Rechtsmedizin. Dissertation. Hamburg: Universität Hamburg; 2012.
12.
go back to reference Hamburger Bürgerschaft. Gesetz zum Schutz der öffentlichen Sicherheit und Ordnung, SOG, §15(4). 1966. Hamburger Bürgerschaft. Gesetz zum Schutz der öffentlichen Sicherheit und Ordnung, SOG, §15(4). 1966.
13.
go back to reference Draughon JE, Hauda WE, Price B, Rotolo S, Austin KW, Sheridan DJ. Factors associated with forensic nurses offering HIV nPEP status post sexual assault. West J Nurs Res. 2015;37:1194–213.CrossRefPubMed Draughon JE, Hauda WE, Price B, Rotolo S, Austin KW, Sheridan DJ. Factors associated with forensic nurses offering HIV nPEP status post sexual assault. West J Nurs Res. 2015;37:1194–213.CrossRefPubMed
14.
go back to reference Draughon Moret JE, Hauda WE, Price B, Sheridan DJ. Nonoccupational postexposure human immunodeficiency virus prophylaxis: acceptance following sexual assault. Nurs Res. 2016;65:47–54.CrossRefPubMed Draughon Moret JE, Hauda WE, Price B, Sheridan DJ. Nonoccupational postexposure human immunodeficiency virus prophylaxis: acceptance following sexual assault. Nurs Res. 2016;65:47–54.CrossRefPubMed
15.
go back to reference Limb S, Kawsar M, Forster GE. HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London. Int J STD AIDS. 2002;13:602–5.CrossRefPubMed Limb S, Kawsar M, Forster GE. HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London. Int J STD AIDS. 2002;13:602–5.CrossRefPubMed
16.
go back to reference Linden JA, Oldeg P, Mehta SD, McCabe KK, LaBelle C. HIV postexposure prophylaxis in sexual assault: current practice and patient adherence to treatment recommendations in a large urban teaching hospital. Acad Emerg Med. 2005;12:640–6.CrossRefPubMed Linden JA, Oldeg P, Mehta SD, McCabe KK, LaBelle C. HIV postexposure prophylaxis in sexual assault: current practice and patient adherence to treatment recommendations in a large urban teaching hospital. Acad Emerg Med. 2005;12:640–6.CrossRefPubMed
17.
go back to reference Loutfy MR, Macdonald S, Myhr T, Husson H, Du Mont J, Balla S, et al. Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors. Antivir Ther. 2008;13:87–95.PubMed Loutfy MR, Macdonald S, Myhr T, Husson H, Du Mont J, Balla S, et al. Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors. Antivir Ther. 2008;13:87–95.PubMed
18.
go back to reference Olshen E, Hsu K, Woods ER, Harper M, Harnisch B, Samples CL. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims. Arch Pediatr Adolesc Med. 2006;160:674–80.CrossRefPubMed Olshen E, Hsu K, Woods ER, Harper M, Harnisch B, Samples CL. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims. Arch Pediatr Adolesc Med. 2006;160:674–80.CrossRefPubMed
19.
go back to reference Templeton DJ, Davies SC, Garvin AL, Garsia RJ. The uptake of HIV post-exposure prophylaxis within a sexual assault setting in Sydney, Australia. Int J STD AIDS. 2005;16:108–11.CrossRefPubMed Templeton DJ, Davies SC, Garvin AL, Garsia RJ. The uptake of HIV post-exposure prophylaxis within a sexual assault setting in Sydney, Australia. Int J STD AIDS. 2005;16:108–11.CrossRefPubMed
20.
go back to reference Wiebe ER, Comay SE, McGregor M, Ducceschi S. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months’ experience in a sexual assault service. Can Med Assoc J. 2000;162:641–5. Wiebe ER, Comay SE, McGregor M, Ducceschi S. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months’ experience in a sexual assault service. Can Med Assoc J. 2000;162:641–5.
21.
go back to reference Krause KH, Lewis-O’Connor A, Berger A, Votto T, Yawetz S, Pallin DJ, et al. Current practice of HIV postexposure prophylaxis treatment for sexual assault patients in an emergency department. Womens Health Issues. 2014;24:e407–12.CrossRefPubMed Krause KH, Lewis-O’Connor A, Berger A, Votto T, Yawetz S, Pallin DJ, et al. Current practice of HIV postexposure prophylaxis treatment for sexual assault patients in an emergency department. Womens Health Issues. 2014;24:e407–12.CrossRefPubMed
22.
go back to reference Chacko L, Ford N, Sbaiti M, Siddiqui R. Adherence to HIV post-exposure prophylaxis in victims of sexual assault: a systematic review and meta-analysis. Sex Transm Infect. 2012;88:335–41.CrossRefPubMed Chacko L, Ford N, Sbaiti M, Siddiqui R. Adherence to HIV post-exposure prophylaxis in victims of sexual assault: a systematic review and meta-analysis. Sex Transm Infect. 2012;88:335–41.CrossRefPubMed
26.
go back to reference Centers for Disease Control and Prevention. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. CDC Stacks. 2016. https://stacks.cdc.gov/view/cdc/38856. Accessed 21 Jul 2017. Centers for Disease Control and Prevention. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. CDC Stacks. 2016. https://​stacks.​cdc.​gov/​view/​cdc/​38856. Accessed 21 Jul 2017.
27.
go back to reference Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54:1–20.PubMed Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54:1–20.PubMed
28.
go back to reference Vernazza PL, Kashuba ADM, Cohen MS. Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2002;45:277–85.CrossRefPubMed Vernazza PL, Kashuba ADM, Cohen MS. Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2002;45:277–85.CrossRefPubMed
29.
go back to reference Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002;1:CD003255. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002;1:CD003255.
30.
go back to reference Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JCG, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS. 2010;24:907–13.CrossRefPubMedPubMedCentral Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JCG, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS. 2010;24:907–13.CrossRefPubMedPubMedCentral
31.
32.
go back to reference Kersh EN, Henning T, Vishwanathan SA, Morris M, Butler K, Adams DR, et al. SHIV susceptibility changes during the menstrual cycle of pigtail macaques. J Med Primatol. 2014;43:310–6.CrossRefPubMedPubMedCentral Kersh EN, Henning T, Vishwanathan SA, Morris M, Butler K, Adams DR, et al. SHIV susceptibility changes during the menstrual cycle of pigtail macaques. J Med Primatol. 2014;43:310–6.CrossRefPubMedPubMedCentral
34.
go back to reference Hösl J. Rechtliche Rahmenbedingungen der HIV-Postexpositionsprophylaxe in Deutschland. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2000;43:S26–30.CrossRef Hösl J. Rechtliche Rahmenbedingungen der HIV-Postexpositionsprophylaxe in Deutschland. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2000;43:S26–30.CrossRef
35.
go back to reference Ford N, Mayer KH. World Health Organization guidelines on postexposure prophylaxis for HIV: recommendations for a public health approach. Clin Infect Dis. 2015;60:S161–4.CrossRefPubMed Ford N, Mayer KH. World Health Organization guidelines on postexposure prophylaxis for HIV: recommendations for a public health approach. Clin Infect Dis. 2015;60:S161–4.CrossRefPubMed
Metadata
Title
The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study
Authors
Julia Ebert
Jan Peter Sperhake
Olaf Degen
Ann Sophie Schröder
Publication date
01-09-2018
Publisher
Springer US
Published in
Forensic Science, Medicine and Pathology / Issue 3/2018
Print ISSN: 1547-769X
Electronic ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-018-9985-7

Other articles of this Issue 3/2018

Forensic Science, Medicine and Pathology 3/2018 Go to the issue

Commentary

Death by food